Biovica International AB (publ) (BIOVIC-B.ST)
SEK 1.62
(-8.47%)
SEK 1.62
(-8.47%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -114.57 Million | -94.64 Million | -52.12 Million | -34.4 Million | -24.78 Million | -17.96 Million |
| Net Income | -124.82 Million | -110.45 Million | -60.1 Million | -39.38 Million | -30.25 Million | -21.52 Million |
| Depreciation & Amortization | 4.34 Million | 8.21 Million | 6.43 Million | 6.14 Million | 4.17 Million | 3.02 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.72 Million | 7.68 Million | 1.71 Million | -864 Thousand | 1.8 Million | -178 Thousand |
| Other non-cash items | 9.14 Million | -86 Thousand | -183 Thousand | -301 Thousand | -497 Thousand | 716 Thousand |
| Investing Cash Flow | -585 Thousand | -2.77 Million | -3.39 Million | -3.56 Million | -7.03 Million | -7.32 Million |
| Investments in PPE | -146 Thousand | -2.77 Million | -3.39 Million | -3.56 Million | -7.03 Million | -7.32 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -439 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -439 Thousand | -1.57 Million | -2.99 Million | -3.56 Million | -7.03 Million | -6.46 Million |
| Financing Cash Flow | 79.5 Million | 122 Million | -136 Thousand | 142.66 Million | 55.74 Million | - |
| Debt repayment | -2.96 Million | -2.9 Million | -1.33 Million | -1.28 Million | -940 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 82.47 Million | 150.09 Million | 1.2 Million | 143.94 Million | 56.68 Million | - |
| Other Financing Activities | -1000.00 | -25.17 Million | -136 Thousand | 142.66 Million | 55.74 Million | - |
| Accounts receivables | -398 Thousand | -716 Thousand | -1.73 Million | -351 Thousand | 1.64 Million | -984 Thousand |
| Accounts payables | 3.7 Million | 8.3 Million | - | -384 Thousand | 111 Thousand | 848 Thousand |
| Inventory | -588 Thousand | 99 Thousand | -1 Million | -129 Thousand | 49 Thousand | -43 Thousand |
| Other working capital | 3.7 Million | 1.00 | 4.45 Million | -384 Thousand | 111 Thousand | 1000.00 |
| Cash at beginning of period | 102.12 Million | 89.79 Million | 145.36 Million | 40.77 Million | 16.83 Million | 42.12 Million |
| Cash at end of period | 66.56 Million | 114.32 Million | 89.79 Million | 145.36 Million | 40.77 Million | 16.83 Million |
| Capital Expenditure | -146 Thousand | -2.77 Million | -3.39 Million | -3.56 Million | -7.03 Million | -7.32 Million |
| Effect of forex changes on cash | 737 Thousand | -54 Thousand | 88 Thousand | -105 Thousand | 19 Thousand | - |
| Net cash flow / Change in cash | -35.55 Million | 24.53 Million | -55.57 Million | 104.58 Million | 23.94 Million | -25.29 Million |
| Free Cash Flow | -114.72 Million | -97.41 Million | -55.52 Million | -37.96 Million | -31.81 Million | -25.29 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -22.88 Million | -39.53 Million | -124.82 Million | -24.6 Million | -24.47 Million | -29.79 Million |
| Depreciation & Amortization | 2.37 Million | 2.36 Million | 4.34 Million | 2.31 Million | 2.39 Million | 2.34 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -7.13 Million | 13.16 Million | 2.72 Million | 1.84 Million | -3.86 Million | -8.42 Million |
| Other non-cash items | -1.39 Million | -9.68 Million | 9.14 Million | -2.31 Million | -2.39 Million | -2.34 Million |
| Investing Cash Flow | - | -145 Thousand | -585 Thousand | 16 Thousand | -456 Thousand | - |
| Investments in PPE | - | -146 Thousand | -146 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | 440 Thousand | -439 Thousand | -440 Thousand | -456 Thousand | - |
| Sales/Maturities of investments | - | - | - | 16 Thousand | - | - |
| Other Investing Activities | - | -439 Thousand | -439 Thousand | 440 Thousand | -456 Thousand | - |
| Financing Cash Flow | 14.8 Million | -779 Thousand | 79.5 Million | 81.85 Million | -809 Thousand | -766 Thousand |
| Debt repayment | -807 Thousand | -634 Thousand | -2.96 Million | -758 Thousand | -809 Thousand | -766 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -145 Thousand | - | - | - | - |
| Common Stock Issuance | 16.41 Million | -146 Thousand | 82.47 Million | 99.26 Million | - | - |
| Other Financing Activities | -807 Thousand | -2.96 Million | -1000.00 | -16.65 Million | - | -766 Thousand |
| Accounts receivables | -184 Thousand | 304 Thousand | -398 Thousand | 555 Thousand | 579 Thousand | - |
| Accounts payables | -7.26 Million | 12.17 Million | 3.7 Million | 1.78 Million | -579 Thousand | - |
| Inventory | 315 Thousand | 686 Thousand | -588 Thousand | -497 Thousand | 19 Thousand | - |
| Other working capital | -7.45 Million | 12.17 Million | 3.7 Million | 1.78 Million | -3.87 Million | -8.42 Million |
| Cash at beginning of period | 79.4 Million | 105.23 Million | 102.12 Million | 46.93 Million | 75.7 Million | 114.32 Million |
| Cash at end of period | 65.2 Million | 66.56 Million | 66.56 Million | 105.23 Million | 46.93 Million | 75.7 Million |
| Capital Expenditure | - | -146 Thousand | -146 Thousand | - | - | - |
| Effect of forex changes on cash | 38 Thousand | 344 Thousand | 737 Thousand | -806 Thousand | 832 Thousand | 368 Thousand |
| Net cash flow / Change in cash | -14.19 Million | -38.67 Million | -35.55 Million | 58.3 Million | -28.77 Million | -38.62 Million |
| Free Cash Flow | -29.04 Million | -25.39 Million | -114.72 Million | -22.76 Million | -28.33 Million | -38.22 Million |
EDRWY
GBK
0425
8433
PLT
PVCT